Patents by Inventor Barbara McEowen Merrill

Barbara McEowen Merrill has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compounds having affinity for the granulocyte-colony stimulating factor receptor (G-CSFR) and associated uses
    Publication number: 20050277588
    Abstract: Novel compounds are provided that bind to G-CSFR. The novel compounds have a peptide chain approximately 6 to 40 amino acids in length that binds to G-CSFR. The compounds are useful as probes for affinity screening. In addition, the compounds have demonstrated agonist or antagonist activity for the G-CSFR, and are therefore useful in treatment of diseases including patients who suffer from a low white blood cell titer. Pharmaceutical compositions and methods of use are provided as well.
    Type: Application
    Filed: August 30, 2004
    Publication date: December 15, 2005
    Inventors: Steven Cwirla, Palani Balu, David Duffin, Sunila Piplani, Barbara McEowen Merrill, Peter Schatz
  • Compounds having affinity for the granulocyte-colony stimulating factor receptor (G-CSFR) and associated uses
    Publication number: 20050037959
    Abstract: Novel compounds are provided that bind to G-CSFR. The novel compounds have a peptide chain approximately 6 to 40 amino acids in length that binds to G-CSFR. The compounds are useful as probes for affinity screening. In addition, the compounds have demonstrated agonist or antagonist activity for the G-CSFR, and are therefore useful in treatment of diseases including patients who suffer from a low white blood cell titer. Pharmaceutical compositions and methods of use are provided as well.
    Type: Application
    Filed: September 9, 2003
    Publication date: February 17, 2005
    Inventors: Steven Cwirla, Palani Balu, David Duffin, Sunila Piplani, Barbara McEowen Merrill, Peter Schatz
  • Compounds having affinity for the granulocyte-colony stimulating factor receptor (G-CSFR) and associated uses
    Patent number: 6716811
    Abstract: Novel compounds are provided that bind to G-CSFR. The novel compounds have a peptide chain approximately 6 to 40 amino acids in length that binds to G-CSFR. The compounds are useful as probes for affinity screening. In addition, the compounds have demonstrated agonist or antagonist activity for the G-CSFR, and are therefore useful in treatment of diseases including patients who suffer from a low white blood cell titer. Pharmaceutical compositions and methods of use are provided as well.
    Type: Grant
    Filed: July 20, 2000
    Date of Patent: April 6, 2004
    Assignee: Affymax, Inc.
    Inventors: Steven E. Cwirla, Palani Balu, David J. Duffin, Sunila Piplani, Barbara McEowen Merrill, Peter J. Schatz